Gabriela Amador(@GabyNeph) 's Twitter Profile Photo

👏🏻 APPLAUSE-3 Trial

👥 w/IgAN and persistent proteinuria >1 g/g

Ictacopan (alternative complement pathway inhibitor) vs placebo

✅ ⬇️ of 38.3% in proteinuria at month 9 (p<0.0001)
✅ 👍🏻 tolerance and safety profile

👏🏻 APPLAUSE-3 Trial

👥 w/IgAN and persistent proteinuria >1 g/g

Ictacopan (alternative complement pathway inhibitor) vs placebo

✅ ⬇️ of 38.3% in proteinuria at month 9 (p<0.0001)
✅ 👍🏻 tolerance and safety profile 

#ISNWCN
account_circle
Jonathan Zuckerman MD PhD(@JZRenalPath) 's Twitter Profile Photo

While I enjoy interesting and challenging cases, I'm certainly glad for the bread and butter cases that come across my desk, such as this case of IgAN in a pt with hematuria and proteinuria. Mesangial IgA deposits and mild mesangial hypercellularity.

While I enjoy interesting and challenging cases, I'm certainly glad for the bread and butter cases that come across my desk, such as this case of IgAN in a pt with hematuria and proteinuria. Mesangial IgA deposits and mild mesangial hypercellularity.  #renalpath #pathtwitter
account_circle
J Daniel Díaz - García(@dano1907) 's Twitter Profile Photo

SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IgAN:

📌 Sustained reduction of proteinuria by Sparsentan:
Primary endpoint was met at the 36-week interim analysis, with a 41% relative reduction in proteinuria (P<.0001).

SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IgAN:

📌 Sustained reduction of proteinuria by Sparsentan: 
Primary endpoint was met at the 36-week interim analysis, with a 41% relative reduction in proteinuria (P<.0001).
account_circle
SERO(@HalldorLevi) 's Twitter Profile Photo

Supporting TheCrowhouse! Proceeds from these two NFTs benefit Max Igan for his impactful work and famous quote. Click the links for purges: [opensea.io/assets/ethereu…]
Second edition NFT Link:
[opensea.io/assets/ethereu…]

account_circle
Cravedi Lab(@cravedilab) 's Twitter Profile Photo

New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN) novartis.com/news/media-rel…

account_circle
The Fringe(@TrueBloodStrong) 's Twitter Profile Photo

The made up catastrophe used by globalists & socialists to instil FEAR & GUILT, to tax, regulate and remove FREEDOMS while pretending to be saving the planet...
rumble.com/v4qlpj2-max-ig…

account_circle
Stephanie Torres M.D.(@stephanietr612) 's Twitter Profile Photo

🚨Iptacopan in IgAN
🗣️ Dana Rizk

APPLAUSE-IgAN Phase 3 ongoing study
🚨🔀 Iptacopan 200mg bid vs Placebo (RASi +/- SGLT2i)
🚨Endpoints 📸⬇️
🚨38.3% proteinuria reduction at 9mo
🚨Tolerated well w favorable safety profile

🚨Iptacopan in IgAN
🗣️ @DanaRizk1 

APPLAUSE-IgAN Phase 3 ongoing study
🚨🔀 Iptacopan 200mg bid vs Placebo (RASi +/- SGLT2i)
🚨Endpoints 📸⬇️
🚨38.3% proteinuria reduction at 9mo
🚨Tolerated well w favorable safety profile

#ISNWCN
account_circle